Agilent Technologies (NYSE:A) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Agilent Technologies (NYSE:A) had its price target hoisted by equities researchers at JPMorgan Chase & Co. from $155.00 to $165.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 20.77% from the company’s current price.

A number of other brokerages also recently weighed in on A. Evercore ISI upped their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a report on Tuesday. Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price objective for the company from $130.00 to $170.00 in a research note on Wednesday. Finally, Robert W. Baird upped their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $148.69.

Agilent Technologies Price Performance

Shares of NYSE A opened at $136.62 on Thursday. Agilent Technologies has a twelve month low of $96.43 and a twelve month high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $38.73 billion, a price-to-earnings ratio of 32.07, a PEG ratio of 4.57 and a beta of 1.26. The firm has a 50-day moving average of $125.04 and a two-hundred day moving average of $117.05.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the company earned $1.32 EPS. Agilent Technologies’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, analysts expect that Agilent Technologies will post 5.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Agilent Technologies

Large investors have recently made changes to their positions in the business. Capital A Wealth Management LLC increased its holdings in shares of Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 212 shares during the period. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $30,000. Opal Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $31,000. Ransom Advisory Ltd acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $32,000. Finally, Central Pacific Bank Trust Division acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at about $33,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.